• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2019 Fiscal Year Final Research Report

Pulmonary fibrosis treatment with pulmonary surfactant as a TLR regulatory molecule and HSP47 inhibition

Research Project

  • PDF
Project/Area Number 17K09662
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionSapporo Medical University

Principal Investigator

Takahashi Hiroki  札幌医科大学, 医学部, 教授 (60231396)

Co-Investigator(Kenkyū-buntansha) 高橋 素子  札幌医科大学, 医学部, 教授 (00303941)
千葉 弘文  札幌医科大学, 医学部, 准教授 (40347175)
大塚 満雄  札幌医科大学, 医学部, 研究員 (10398323)
黒沼 幸治  札幌医科大学, 医学部, 講師 (40563250)
Project Period (FY) 2017-04-01 – 2020-03-31
Keywords肺サーファクタント / 肺傷害 / 間質性肺炎 / 内科 / 免疫学
Outline of Final Research Achievements

Objective: To develop a new therapeutic method for idiopathic pulmonary fibrosis under the hypothesis that surfactant protein (SP) -A supplementation and HSP47 siRNA suppress lung inflammation and fibrosis. Method: BLM was intratracheally administered to SP-A (-/-) and wild-type mice to prepare a lung injury / fibrosis model, and siRNA HSP47 was intravenously administered. Results: Inflammation and fibrosis were enhanced in SP-A deficient mice compared to wild type. In addition, siRNA HSP47 reduced lung injury and suppressed BLM-induced airway inflammation. Conclusion: SP-A supplementation and siRNA HSP47 suppressed the formation of lung injury / fibrotic lesions, and it was shown that the combination of both could be one of the new treatments for pulmonary fibrosis.

Free Research Field

呼吸器内科学

Academic Significance and Societal Importance of the Research Achievements

特発性肺線維症は予後が三年程度の難治性疾患であり、自然免疫の破綻と線維の過剰産生が悪化のメカニズムに関与している。肺線維症の動物モデルで検討した結果、自然免疫調整因子であるサーファクタント蛋白質(SP)-Aが欠損すると病変が悪化し、また、siRNA HSP47で線維生成を抑制することによって悪化が抑制された。したがって、両者の併用が肺線維症の新たな治療法のひとつになりうることが示された。

URL: 

Published: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi